Study of the Effect of the Addition of SNDX-275 (Entinostat) to Continued Aromatase Inhibitor (AI) Therapy in Postmenopausal Women With ER+ Breast Cancer Whose Disease is Progressing
Clinical trial NCT00828854 · COMPLETED
Trial details
- NCT number
- NCT00828854
- Sponsor
- Syndax Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-10-01
- Primary completion
- 2009-11-24
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.